Monoclonal antibodies targeting the rabies virus glycoprotein promotes viral clearance and Fc-dependent neuroprotection in the infected brain
Seonhee Kim, Anthony Coléon, Florence Larrous, Lauriane Kergoat, Saïd Mougari, Julien Lannoy, Marta Simone Fabrício Tiago, David Hardy, Étienne Kornobis, Felix Augusto Rey, Fabio Benigni, Davide Corti, Hervé Bourhy, Guilherme Dias de Melo
This study evaluates monoclonal antibodies RVC20 and RVC58 for treating symptomatic rabies in mice, showing that intravenous and intramuscular administration can clear viral infection and improve survival, with RVC58 achieving 80% survival.
bioRxiv · Jun 16, 2026 · PreprintMicrobiology